Clinical Trials Browser

Recruiting × Neuroblastoma × tipifarnib × Clear all

NCT06540963 2026-03-02

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Phase 2 Recruiting

Neuroblastoma